AMPH - Amphastar P logo

AMPH

Amphastar P

Amphastar Pharmaceuticals develops, manufactures, and sells generic and proprietary injectable, inhalation, and intranasal products. Its portfolio includes treatments for emergencies like hypoglycemia and opioid overdose, along with various APIs and specialty medications.

โš•๏ธ Healthcare NASDAQ Listed 2014 $ USD
$1,000 invested 10 years ago โ†’$1,104today

Score Overview

1 Year
Score
Net Growth-19.93%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth1.41%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score6.2
Net Growth26.45%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth66.76%
Rev Trend80%
Revenue Consistencyโ€”
10 Years
Score
Net Growth7x
Net Trend50%
Net Income Consistency
Rev Growth186.10%
Rev Trend80%
Revenue Consistency
All Time
Score
Net Growth9x
Net Trend58%
Net Income Consistency
Rev Growth246.87%
Rev Trend83%
Revenue Consistency

See the full market ranking โ†’

Amphastar P fundamental performance

Between 2020 and 2025, revenue grew from $ 349M to $ 719M and net income grew from $ 1M to $ 98M. Revenue increased in 4 of those 5 years; net income in 3.

Between 2015 and 2025, revenue grew from $ 251M to $ 719M and net income went from -$ 2M to $ 98M. Revenue increased in 8 of those 10 years; net income in 5.

Amphastar P currently holds a 5-year HDB Score of 6.2 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 19.98โ€”
1 Year2025-08-12
$ 30.35-34.17%
5 Years2021-08-12
$ 19.532.30%
10 Years2016-08-12
$ 18.1010.39%
All Time2014-06-25
$ 8.75128.34%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 730M$ 78M$ 290M
2025$ 719M$ 98M$ 282M
2024$ 731M$ 159M$ 221M
2023$ 644M$ 137M$ 256M
2022$ 498M$ 91M$ 175M
2021$ 437M$ 62M$ 136M
2020$ 349M$ 1M$ 105M
2019$ 322M$ 48M$ 89M
2018$ 294M-$ 5M$ 89M
2017$ 240M$ 4M$ 68M
2016$ 255M$ 10M$ 72M
2015$ 251M-$ 2M$ 66M
IPO2014$ 210M-$ 10M$ 67M

Explore beyond AMPH

You're looking at Amphastar P. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies